26.01.2018 • News

Ex-Lilly Executive Confirmed as US Health Secretary

Former Eli Lilly executive Alex Azar was confirmed by the US Senate as new...
Former Eli Lilly executive Alex Azar was confirmed by the US Senate as new Secretary of the Department of Health and Human Services (HHS) (c) HHS.gov

By vote of 55 to 43, former Eli Lilly executive Alex Azar was confirmed by the US Senate as new Secretary of the Department of Health and Human Services (HHS) on Jan. 24.

Azar formerly headed pharmaceutical giant Lilly’s US operations, but also has experience at HHS, where he served as general counsel from 2001 to 2005 and later as deputy secretary.

As secretary, Azar replaces Tom Price, former US representative from Georgia’s sixth congressional district. Price was forced to step down last year after it emerged that he had spent government funds on personal travel.

In his new job, the former pharma manager will be responsible for overseeing $1.13 trillion in department spending and supervising research and administering health programs.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.